Menu
Back to Journals » Cancer Management and Research
ISSN: 1179-1322
- View all (4867)
- Volume 17, 2025 (109)
- Volume 16, 2024 (164)
- Volume 15, 2023 (153)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Journal Articles:
- 4,867 records -
The Prognostic Value of Combined Systemic Immune-Inflammatory Index (SII) and Prognostic Nutritional Index (PNI) in Solid Tumor
Zhang Y, Tang M, Gu QH, Zhou LN, Chen MB
Cancer Management and Research 2025, 17:1351-1359
Published Date: 8 July 2025
Integrating Deep Learning and Radiomics in Differentiating Papillary Thyroid Microcarcinoma from Papillary Thyroid Carcinoma with Ultrasound Images
Yu B, He H, Zheng Q, Ai Y, Yu X, Li S, Zhang J, Jin J, Jin X, Yu W
Cancer Management and Research 2025, 17:1339-1349
Published Date: 8 July 2025
Regulatory Role and Mechanism of lncRNA RNF217-AS1 in the Proliferation and Migration of Esophageal Cancer Cells
Liang J, Niu X, Wang G, Wang M
Cancer Management and Research 2025, 17:1329-1337
Published Date: 7 July 2025
Distinct Lung Adenocarcinoma-Associated Microbiota Are Associated with Inflammatory Immune Landscapes and Tumor Cell Proliferation via LCIIAR–ISG15 Regulatory Networks
Liu S, Zhang Z
Cancer Management and Research 2025, 17:1315-1328
Published Date: 4 July 2025
EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway [Retraction]
Zhang R, Han D, Li L, Luo W, Liu J, Qian L
Cancer Management and Research 2025, 17:1313-1314
Published Date: 5 July 2025
Retrospective Analysis of the Timing of Radiotherapy Intervention After Induction Chemoimmunotherapy in Unresectable Locally Advanced Lung Squamous Cell Carcinoma
Zeng L, Zhang Y, Zeng A, Ma D
Cancer Management and Research 2025, 17:1301-1311
Published Date: 3 July 2025
Integrated Traditional Chinese and Western Medicine in Lung Adenocarcinoma with Rare EGFR Mutation and Nephrotic Syndrome: A Case Report
Zhang L, Cai L, Ruan L, Li J
Cancer Management and Research 2025, 17:1293-1299
Published Date: 2 July 2025
Impact of Social Determinants on Quality of Life in Socioeconomically Disadvantaged Cancer Survivors: A Mixed-Methods Study
Almutairi M, Almutairi AA, Alodhialah AM
Cancer Management and Research 2025, 17:1271-1292
Published Date: 1 July 2025
Latent Profile Analysis of Emotional Expression Conflicts and Associated Influencing Factors in Breast Cancer Patients Receiving Postoperative Chemotherapy
Tian Z, Sheng R, Zhang Y, Li H
Cancer Management and Research 2025, 17:1259-1269
Published Date: 1 July 2025
Optimizing Scalp Cooling: (Ultra)Structural Follicular Characteristic and Restorative Advances
Schaffrin-Nabe D, Josten-Nabe A, Heinze A, Tannapfel A, Schaffrin M, Voigtmann R
Cancer Management and Research 2025, 17:1245-1257
Published Date: 30 June 2025
Associations Between Postoperative Symptom Clusters and Functional Status in Lung Cancer Patients: A Cross-Sectional Study [Corrigendum]
Liu Y, Lin S, Bai M, Yi H
Cancer Management and Research 2025, 17:1243-1244
Published Date: 26 June 2025
Clinicopathological Features and Prognostic Factors of Renal Cell Carcinoma in Young Patients Under 45 Years: A Single-Center Retrospective Study
Gao Y, Yan H, Zhang T, Lu G, Ma L
Cancer Management and Research 2025, 17:1233-1242
Published Date: 25 June 2025
Experiences with Higher-Risk Myelodysplastic Syndromes and Improving Patient-Centered Treatment Decision-Making: A Qualitative Study of Patients, Caregivers, and Providers
Maravic MC, Land N, Prood N, Cagle C, May SG, Batt K, Sabate EJ, Afulezi N, Jhaveri TZ, Iraca T, Hogea C
Cancer Management and Research 2025, 17:1215-1232
Published Date: 24 June 2025
Secondary Analysis of PSA and BCR-Free Survival in Asian Prostate Cancer Patients
Gao X, Fu Y, Mo Z, Ruan Y
Cancer Management and Research 2025, 17:1205-1214
Published Date: 24 June 2025
Impact of Intravenous Fish Oil Lipid Emulsion on Short-Term Postoperative Outcomes in Rectal Cancer Patients Following Neoadjuvant Therapy: A Propensity Score-Matched Study
Yang L, Pi F, Wei Z, Peng X
Cancer Management and Research 2025, 17:1195-1203
Published Date: 24 June 2025
Effectiveness and Safety of Neoadjuvant Immunochemotherapy with and without Surgery in Patients with Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study
Liao X, Chen X, Hong W, Chen F, Li G, Li L
Cancer Management and Research 2025, 17:1185-1193
Published Date: 20 June 2025
Risk Factors of Non-Classic Radiation-Induced Liver Disease (ncRILD) After Intensity-Modulated Radiotherapy in Hepatocellular Carcinoma
Du YQ, Tao SP, Li JX, Zhao YN
Cancer Management and Research 2025, 17:1169-1183
Published Date: 18 June 2025
A Retrospective Analysis Comparing the Dosimetric Parameters of Two Rectum-Sparing Techniques During Intracavitary Brachytherapy with Tandem-Ring Applicators for Cervical Cancer
Vats S, Thakur S, Gupta M, Kumar V, Chandrakant L, Negi M, Sharma P, Fotedar V, Thakur P, Tuli D, Vias P, Sharma J, Negi A, Kaushal S, Upadhyay M, Negi N, Sharma A, Azad A, Parihar N, Verma D
Cancer Management and Research 2025, 17:1155-1168
Published Date: 17 June 2025
Jujuboside B Inhibits the Proliferation and Migration of Non-Small Cell Lung Cancer H1299 Cells Through Inhibiting PI3K/Akt and Wnt/β-Catenin Pathways
Chen M, Li J, Hu S, Wang Y, Wang K, Wang T
Cancer Management and Research 2025, 17:1143-1153
Published Date: 16 June 2025
Integrating Machine Learning Algorithms to Construct a Triaptosis-Related Prognostic Model in Melanoma
Xie J, Zhang M, Qi M
Cancer Management and Research 2025, 17:1127-1141
Published Date: 13 June 2025
Modulation of Chronic Cytokine Dysregulation in Cervical Cancer: Potential Biomarkers and Therapeutic Targets
Obeagu EI
Cancer Management and Research 2025, 17:1113-1126
Published Date: 13 June 2025
Associations Between Postoperative Symptom Clusters and Functional Status in Lung Cancer Patients: A Cross-Sectional Study
Liu Y, Lin S, Bai M, Yi H
Cancer Management and Research 2025, 17:1099-1111
Published Date: 12 June 2025
Potential of Using New Indole- and Benzimidazo[1,2-C]quinazolines in Anticancer Therapy Based on Mesenchymal Stem Cells
Radzikowska-Bűchner E, Radej S, Niezabitowska E, Sitarz R, Szewc M
Cancer Management and Research 2025, 17:1087-1097
Published Date: 11 June 2025
Advances in Multimodal Imaging Techniques for Evaluating and Predicting the Efficacy of Immunotherapy for NSCLC
Liu J, Xie M, Shen J, Yao J, Lin X, Bao X, Zhang X, Liang Y, Yang Y, Jiang G, Diao X, Han W, Du H, Xue X, Wu J
Cancer Management and Research 2025, 17:1073-1086
Published Date: 7 June 2025
Long Non-Coding RNA TPTEP1 Exerts Tumor Suppressive Functions via Sequestering miR-4295 to Regulate Growth Arrest and DNA Damage-Inducible 45α Expression in Acute Myeloid Leukemia
Liu X, Gui Y, Wang C, Xia K, Yang P
Cancer Management and Research 2025, 17:1059-1072
Published Date: 4 June 2025
Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy Patients
Ni W, Wang X, Wang Q, Ge Y, Mu X
Cancer Management and Research 2025, 17:1047-1058
Published Date: 28 May 2025
Anticancer Potential of Bioactive Compounds in Premna serratifolia, Premna odorata, and Premna tomentosa: A Review of In Vitro Evidence
Febriyanti RM, Rafif SN, Mikdar NN, Hikmatiana BN, Maisyarah IT, Khatib A, Muhaimin M
Cancer Management and Research 2025, 17:1029-1045
Published Date: 27 May 2025
A Comprehensive Study of Part-Solid Lung Adenocarcinoma with Lymph Node Metastasis: Clinical, Pathological, and Radiological Perspectives
Zhao Z, Gan H, Fu BJ, Li W, Lv F, Chu Z
Cancer Management and Research 2025, 17:1015-1027
Published Date: 26 May 2025
Expression and Diagnostic Value of Nrf2 and p62 in Cervical Squamous Cell Carcinoma and Intraepithelial Lesions
Wei W, Hu X, Han Q
Cancer Management and Research 2025, 17:1005-1013
Published Date: 24 May 2025
Risk Factors and Prognostic Implications in Synchronous Breast-Thyroid Dual Primary Cancers: A Matched Case-Control Study
Li T, Lu B, Zhang Y, Zhang P, Qi J, Sun Y
Cancer Management and Research 2025, 17:997-1004
Published Date: 24 May 2025
The Naples Prognostic Score Exerts a Significant Impact on the Prognosis of Patients Diagnosed with External Auditory Canal Carcinoma After Surgery
Xu XL, Cheng H, Wu XM, Xu JH
Cancer Management and Research 2025, 17:985-996
Published Date: 25 May 2025
Correlation of PET/CT Maximal Standardized Uptake Values with Clinicopathologic Parameters of Aggressive Non-Hodgkin’s Lymphoma
Li Y, Wu D, Tian M
Cancer Management and Research 2025, 17:975-984
Published Date: 22 May 2025
Association of PD-L1 Expression with Lymph Node Metastasis and Clinical Stage in Ampulla of Vater Cancer: An Observational Study
Andrianto A, Rudiman R, Ruchimat T, Lukman K, Sulthana BAAS, Purnama A, Wijaya A, Primastari E, Nugraha P
Cancer Management and Research 2025, 17:965-974
Published Date: 13 May 2025
IL-38 as a Novel Biomarker in Multiple Myeloma Patients: A Prospective Clinical Evaluation
Shen H, Zhao P, Cao J
Cancer Management and Research 2025, 17:955-964
Published Date: 10 May 2025
A Nomogram Based on Fibrinogen-to-Neutrophil Ratio as a Novel Predictor of Lymph Node Metastasis in Patients with Cervical Cancer and Type 2 Diabetes Mellitus
Kuang H, Yang D, Lin R, Tang Y, Luo Y, Wang S, Xia T, Lou G, Chen H
Cancer Management and Research 2025, 17:933-954
Published Date: 10 May 2025
A Machine Learning Model for Predicting Breast Cancer Recurrence and Supporting Personalized Treatment Decisions Through Comprehensive Feature Selection and Explainable Ensemble Learning
Lee TF, Shiau JP, Chen CH, Yun WP, Wuu CS, Huang YJ, Yeh SA, Chen HC, Chao PJ
Cancer Management and Research 2025, 17:917-932
Published Date: 8 May 2025
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral Melanoma
Zhang J, Tian H, Mao L, Li C, Wei X, Gu J, Wang X, Zhou L, Lian B, Tang B, Yan X, Li S, Cui C, Chi Z, Sheng X, Guo J, Si L
Cancer Management and Research 2025, 17:905-916
Published Date: 1 May 2025
Recurrence Prediction by Multi-Omics in the Patient with Colorectal Peritoneal Metastases After Cytoreductive Surgery: A Prospective Biomarker Study
Chen C, Gong Z, Zhang Z, Gu H, Zhu A, Peng D, Li B, Wang J, Hu Y, Wang D, Sun L
Cancer Management and Research 2025, 17:893-904
Published Date: 29 April 2025
Prediction of Ki-67 Expression in HIV-Associated Lung Adenocarcinoma Patients Using Multiple Machine Learning Models Based on CT Imaging Radiomics
Song C, Chen J, Zhao C, Song S, Yang T, Huang A, Liu R, Pan Y, Xu C, Chen C, Zhu Q
Cancer Management and Research 2025, 17:881-892
Published Date: 25 April 2025
The Value of Integrating Hormone Receptors into Immunohistochemistry-Based Simplified Molecular Classification in Endometrial Cancer
Zhao S, Yan Y, Wang T, Zhang J, Zheng X, Li X, Zhao J, Yang E, Zhao X, Tian L, Xue F, Tian W, Wang Y
Cancer Management and Research 2025, 17:869-880
Published Date: 24 April 2025
The Role of Cavin3 in the Development of Malignant Tumors
Qian L, Zhang Z, Cai H
Cancer Management and Research 2025, 17:863-868
Published Date: 23 April 2025
Impact of the Basic Mandatory Health Insurance “AMO-Tadamon” on Continuity of Care Among Breast Cancer Patients Treated at the Oncology Center of the CHU Mohammed VI in Tangier: A Mixed Longitudinal Cohort Study
Bouzini G, Amzerin M, Mahdi Z, Sammoud K, Chahbar A, Najdi A, El m’rabet FZ
Cancer Management and Research 2025, 17:851-861
Published Date: 21 April 2025
Blood-Based Prognostic Prediction Model for Glioblastoma: Construction and Validation
Gao S, Liu Y, Kong J, Huangfu L, Yang Y, Cui H, Sun X, Shi S, Yang D
Cancer Management and Research 2025, 17:835-850
Published Date: 18 April 2025
A Case Report of Pulmonary Malignant Melanoma with Multiple Intracranial Hemorrhagic Metastases
Zhang J, Yang G, Peng S, Fang Y
Cancer Management and Research 2025, 17:829-833
Published Date: 17 April 2025
Silencing of LncRNA SNHG16 Downregulates Cyclin D1 (CCND1) to Abrogate Malignant Phenotypes in Oral Squamous Cell Carcinoma (OSCC) Through Upregulating miR-17-5p [Retraction]
Wang Q, Han J, Xu P, Jian X, Huang X, Liu D
Cancer Management and Research 2025, 17:827-828
Published Date: 16 April 2025
Predicting the Efficacy of Immune Checkpoint Inhibitors in Esophageal Cancer: Changes in Peripheral Blood Lymphocyte Subsets Before and After Immunotherapy
Cao R, Jiao P, Zhang S, Li J, Liu Q
Cancer Management and Research 2025, 17:815-825
Published Date: 16 April 2025
Impact of the Timing of Protective Stoma Reversal on Survival in Rectal Cancer Patients Undergoing Postoperative Adjuvant Chemotherapy: A Retrospective Single Center Study
Wang J, Lu X, Xu Y, Wu Y, Zhang T, Li J
Cancer Management and Research 2025, 17:801-814
Published Date: 15 April 2025
Combination Therapy of Transarterial Chemoembolization, Lenvatinib, and PD-1 Inhibitors Achieves Significant Tumor Response in Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Report
Fu Y, Wu J, Wu J, Li Y, Zeng Z, Liu D, Li H, Ou X, Lin Z, Wei S, Song H, Yan M
Cancer Management and Research 2025, 17:793-799
Published Date: 13 April 2025
Traditional Chinese Medicine as a Tool for the Treatment of Hepatocellular Carcinoma by Targeting Pathophysiological Mechanism
Lu J, Liu X, Fan K, Lin X
Cancer Management and Research 2025, 17:779-792
Published Date: 8 April 2025
Treatment and Outcomes of Primary Tracheal Adenoid Cystic Carcinoma: A Systematic Review
Shi Y, Xue S, Zou J
Cancer Management and Research 2025, 17:767-778
Published Date: 5 April 2025